THE ORCHARD PARTNERSHIP — All Prescriptions & Medications — Page 2
Practice Code: J83019 | SALISBURY, SP2 0JU
Showing results 51-100 of 707
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Mirabegron | 1,597 | 36.6K | £32.1K | +297.6% ▲ |
| Finasteride | 1,554 | 39.8K | £1.5K | +137.3% ▲ |
| Gliclazide | 1,524 | 74.0K | £3.1K | +79.1% ▲ |
| Gabapentin | 1,487 | 133.8K | £5.8K | +48.9% ▲ |
| Atenolol | 1,380 | 34.3K | £810 | +128.9% ▲ |
| Morphine sulfate | 1,363 | 214.8K | £7.9K | +107.9% ▲ |
| Lisinopril | 1,326 | 37.6K | £924 | +21.0% ▲ |
| Tramadol hydrochloride | 1,321 | 109.1K | £3.5K | +84.3% ▲ |
| 1,310 | 23.3K | £11.2K | +97.2% ▲ | |
| Codeine phosphate | 1,296 | 84.3K | £2.8K | +80.4% ▲ |
| Felodipine | 1,295 | 34.6K | £5.1K | +118.1% ▲ |
| Latanoprost | 1,291 | 18.5K | £5.9K | +166.0% ▲ |
| Diazepam | 1,239 | 29.7K | £662 | +148.8% ▲ |
| Montelukast | 1,210 | 33.0K | £1.6K | +76.7% ▲ |
| Ibuprofen | 1,210 | 123.3K | £5.4K | +137.9% ▲ |
| Glucose blood testing reagents | 1,163 | 96.4K | £12.1K | +47.4% ▲ |
| Escitalopram | 1,130 | 30.2K | £2.1K | +297.0% ▲ |
| Alogliptin | 1,123 | 26.9K | £23.4K | +342.8% ▲ |
| Amoxicillin | 1,118 | 38.5K | £1.5K | +19.9% ▲ |
| Doxycycline hyclate | 1,117 | 15.0K | £1.5K | +117.9% ▲ |
| Donepezil hydrochloride | 1,101 | 18.1K | £750 | +256.8% ▲ |
| 1,097 | 11.7K | £3.3K | +339.7% ▲ | |
| Ferrous fumarate | 1,083 | 49.5K | £2.1K | +49.4% ▲ |
| Ezetimibe | 1,074 | 26.4K | £4.8K | +51.0% ▲ |
| Co-dydramol (Dihydrocodeine/paracetamol) | 1,059 | 93.9K | £4.5K | +489.3% ▲ |
| Spironolactone | 1,027 | 25.1K | £3.3K | +90.5% ▲ |
| Rivaroxaban | 1,014 | 25.6K | £16.6K | +65.7% ▲ |
| Quinine sulfate | 999 | 22.8K | £3.8K | +245.1% ▲ |
| Senna | 990 | 41.4K | £944 | +64.5% ▲ |
| Sildenafil (Erectile Dysfunction) | 987 | 7,028 | £1.0K | +95.8% ▲ |
| Duloxetine hydrochloride | 973 | 25.6K | £2.4K | +53.1% ▲ |
| Solifenacin | 945 | 23.1K | £966 | +98.1% ▲ |
| Lamotrigine | 942 | 50.4K | £12.9K | +59.5% ▲ |
| Fluticasone/umeclidinium/vilanterol | 940 | 967 | £39.2K | +301.0% ▲ |
| Famotidine | 930 | 25.8K | £15.7K | +90.6% ▲ |
| Tirzepatide | 921 | 945 | £87.1K | +374.2% ▲ |
| Nitrofurantoin | 918 | 10.4K | £5.3K | +92.4% ▲ |
| Methotrexate | 916 | 14.6K | £16.0K | +181.4% ▲ |
| Budesonide | 908 | 1,031 | £23.3K | +67.5% ▲ |
| Digoxin | 907 | 19.3K | £1.4K | +139.7% ▲ |
| Estradiol | 906 | 21.7K | £9.5K | +235.8% ▲ |
| Fluticasone propionate (Inhalation) | 870 | 979 | £20.4K | +124.8% ▲ |
| Hydrocortisone | 844 | 26.4K | £4.5K | +88.2% ▲ |
| Fluticasone furoate/vilanterol | 835 | 884 | £19.6K | +439.3% ▲ |
| Alginic acid compound preparations | 823 | 427.7K | £5.6K | +40.5% ▲ |
| Buprenorphine | 822 | 2,884 | £11.2K | +124.4% ▲ |
| Carbocisteine | 817 | 100.0K | £3.9K | +53.0% ▲ |
| 816 | 1,740 | £56.6K | +49.7% ▲ | |
| Quetiapine | 813 | 21.0K | £6.2K | +30.6% ▲ |
| Mometasone furoate | 774 | 796 | £6.1K | +92.8% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.